Is NASDAQ:ALKS suited for growth investing?

Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if ALKERMES PLC (NASDAQ:ALKS) is suited for growth investing. Investors should of course do their own research, but we spotted ALKERMES PLC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.

Why NASDAQ:ALKS may be interesting for growth investors.

• With a favorable Return on Equity (ROE) of 15.85%, ALKERMES PLC demonstrates its ability to deliver attractive returns for shareholders. This metric highlights the company's effective management of assets and its profitability.
• With a track record of beating EPS estimates in the last 4 quarters, ALKERMES PLC showcases its consistent ability to deliver earnings surprises. This reflects the company's strong execution and its competitive position in the market.
• With impressive 1-year revenue growth of 40.56%, ALKERMES PLC showcases its ability to generate increased sales and revenue. This growth highlights the company's strong customer demand and its effective business strategies.
• The q2q revenue growth of 50.91% of ALKERMES PLC highlights the company's ability to generate incremental revenue and suggests positive market demand for its products or services.
• The operating margin of ALKERMES PLC has seen steady growth over the past year, signaling improved profitability. This trend indicates the company's effective cost management and its ability to generate higher returns.
• The free cash flow (FCF) of ALKERMES PLC has seen steady growth over the past year, indicating enhanced cash flow generation and financial health. This trend underscores the company's effective capital management and its ability to generate sustainable cash flows.
• The quarterly earnings of ALKERMES PLC have shown a 3.0K% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
• ALKERMES PLC has seen a 31.43% change in the average next Quarter EPS Estimate by analysts over the last 3 months, signaling the shifting perception of the company's EPS outlook.
• The quarterly earnings of ALKERMES PLC have shown a 3.0K% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
• The earnings per share (EPS) growth of ALKERMES PLC are accelerating: the current Q2Q growth of 3.0K% is above the previous year Q2Q growth of -85.71%. Earnings momentum and acceleration are key for high growth systems.

A complete fundamental analysis of NASDAQ:ALKS

At ChartMill, a crucial aspect of their analysis is the assignment of a Fundamental Rating to each stock. This rating, ranging from 0 to 10, is calculated daily by considering numerous fundamental indicators and properties.

ALKS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 598 industry peers in the Biotechnology industry. ALKS has only an average score on both its financial health and profitability. ALKS has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! With these ratings, ALKS could be worth investigating further for value and growth investing!.

Check the latest full fundamental report of ALKS for a complete fundamental analysis.

More ideas for growth investing can be found on ChartMill in our Lois Navellier screen.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.